Search

Your search keyword '"Kennedy, Laurence"' showing total 328 results

Search Constraints

Start Over You searched for: Author "Kennedy, Laurence" Remove constraint Author: "Kennedy, Laurence"
328 results on '"Kennedy, Laurence"'

Search Results

1. Levoketoconazole treatment in endogenous Cushings syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes.

7. Acromegaly: a clinical perspective

9. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States

15. LBMON178 2nd Year Outcomes Of The Open-label Extension Of Chiasma Optimal, A Phase 3 Study Of Oral Octreotide Capsules In Acromegaly

16. PMON166 Safety Comparison of 40- vs 60-mg/day Doses of Oral Octreotide Capsules for Treatment of Acromegaly in the CHIASMA OPTIMAL Trial

17. Durable biochemical response and safety with oral octreotide capsules in acromegaly

20. Levoketoconazole treatment in endogenous Cushing’s syndrome:extended evaluation of clinical, biochemical, and radiologic outcomes

22. Safety comparison of 40- vs 60- mg/day doses of oral octreotide capsules for treatment of acromegaly in the chiasma optimal trial

27. Response to Letter to the Editor From Lukas Andereggen: “Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review”

29. One-Year Outcomes of the Open-Label Extension of CHIASMA OPTIMAL, a Phase 3 Study of Oral Octreotide Capsules in Acromegaly

32. Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review

34. Diabetes

40. IGF-I variability and its association with demographic and clinical characteristics in patients with acromegaly treated with injectable somatostatin receptor ligands (SRLs); results from OPTIMAL, an international prospective phase 3 study

41. Biochemical control of most patients reverting to injectable long-acting somatostatin receptor ligands is achieved after one dose: Results from the phase 3, randomized, double blind, placebo-controlled optimal study

42. Levoketoconazole in the treatment of endogenous Cushing’s syndrome: Extended evaluation phase results of the SONICS study

43. Impact of imputation method on efficacy results from the phase 3 optimal study of oral octreotide capsules in adult patients with acromegaly

44. Results from the phase 3, randomized, double-blind, placebo-controlled OPTIMAL study of oral octreotide capsules in adult patients with acromegaly

45. Analysis of adverse events in adult patients with acromegaly receiving oral octreotide capsules: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

46. Withdrawal from long-acting somatostatin receptor ligand injections in adult patients with acromegaly: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

47. Sustained response to treatment with oral octreotide capsules: Results from the phase 3, randomized, double blind, placebo-controlled optimal study

48. Patients receiving a range of doses of prior injectable somatostatin receptor ligands respond to oral octreotide in the treatment of acromegaly: Results from the phase 3 optimal study

49. Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

50. Acromegaly: a Clinical Perspective

Catalog

Books, media, physical & digital resources